Identifying Factors Related to the Survival of AIDS Patients under the Follow-up of Antiretroviral Therapy (ART): The Case of South Wollo

Jemal Ayalew¹, Helen Moges¹, Omprakash sahu^2, and Anteneh Worku²

¹Department of Statistics, College of Natural Sciences, Wollo University, Ethiopia

²Department of Chemical Engineering, KIOT Wollo University Kombolcha Ethiopia

Cite this paper:
Jemal Ayalew, Helen Moges, Omprakash sahu and Anteneh Worku. Identifying Factors Related to the Survival of AIDS Patients under the Follow-up of Antiretroviral Therapy (ART): The Case of South Wollo. International Journal of Data Envelopment Analysis and *Operations Research*. 2014; 1(2):21-27. doi: 10.12691/ijdeaor-1-2-2

Abstract

The expansion of HIV/ADIS epidemic has now become a burning issue globally. HIV infection has changed from a fatal condition to a manageable chronic illness mainly due to the development of antiretroviral therapy (ART). Even if ART treatment has shown significant clinical importance by meeting the goal of therapy, we are still facing a number of deaths due to certain socio-economic, demographic, behavioral risk and health factors. The aim of this study is for identifying determinant factors for the Survival of HIV/ADIS Infected Patients under the follow-up of antiretroviral therapy (ART) at Boru Meda and Dessie Referral Hospitals and Kombolcha Health Center. The data for this research were collected during the follow-up time from January 1, 2008 to December 31, 2011. Out of a population of HIV-patients who were taking antiretroviral therapy in the hospitals and health center in that period, 654 patients were selected based on simple random sampling technique for this study. The study subjects were people in the age range from 15 to 75 years. The Kaplan-Meier Method was employed to estimate survival; the Cox Proportional Hazards Regression Method was used to identify determinants of survival. After initiation of the antiretroviral treatment, HIV-positive patients the estimate median survival age was found to be 48 months (CI: 2.98-4.97 years). Living rural, order baseline age, not working due to illness, smaller CD4 count, weight, and lymphocyte count, HIV-TB co-infection developing and being in WHO clinical Stage IV were identified as a documented risk factors for shortened the survival experience of the HIV-patients who are in care of ART. The mortality among our patients was comparable to that reported from other low-income countries. Earlier initiation of ART may reduce the high mortality rates observed. Similar studies in the future need to consider predictors in addition to those considered in this study and the clinical advantage of ART that brings improvement on the clinical characteristics in the follow up period.

Keywords:
antiretroviral bacterial infection global patients

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Federal HIV/AIDS Prevention and Control Office (HAPCO). Country Progress Report on HIV/AIDS Response, Federal Democratic Republic of Ethiopia. 2012.
[2]	UNAIDS/WHO. AIDS epidemic update UNAIDS 20 avenues Appia CH-1211 Geneva 27 Switzerland, 2009.
[3]	USAID. HIV/AIDS Health Profile for Ethiopia. AA. Ethiopia Wikipedia, the free encyclopedia (2008). List of countries by HIV/AIDS Adult prevalence rate. 2010; http://en.wikipedia.org/wiki, Accessed on 30/05/10
[4]	Odafe S., Idoko O., Badru T., Aiyenigba B., Suzuki C., Khamofu H., Onyekwena O., Okechukwu E., Torpey K. and Chabikuli1 O. N. Patients’ demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals. 2012; 15: 17424.
[5]	Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of antiretroviral agents in HIV-1 Infected Adults and Adolescents. 2008.
[6]	United Nations Programme on HIV/AIDS (UNAIDS). Report on the Global HIV/AIDS Epidemic, Geneva. 2006.
[7]	Rogers, P., Sinka K., Molesworth A., Evans B., and Allardice G.. Survival after diagnosis of AIDS among adults resident in the United Kingdom in the era of multiple therapies. Commun Dis Public Health, 2001; 3: 188-94.
[8]	Zahang C. HIV/AIDS relative survival analysis, M.Sc. thesis. Georgia state university, in the college of arts and sciences. 2007: 79 p.
[9]	Tegiste Assefa and Eshetu Wencheko. Survival analysis of patients under chronic HIV-care and antiretroviral treatment at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. 2012; 26 (1): 22-29.
[10]	Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457-481.
[11]	Cox D.R. Regression models and life tables (with Discussion). Journal of the Royal Statistical Society 1972; Series B, 34: 187-220.
[12]	Hosmer DW, Lemeshow S, May S. 2008. Applied Survival Analysis, 2nd Edition. John Wiley & Sons, Inc., New York.
[13]	Andinet Worku Alemu and Miguel San Sebastián. Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. PMC, 2010.
[14]	Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008; 8:5 2.
[15]	Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2009; 14: 36-43.
[16]	Lee S. H., Kim K., Lee S. G., Cho H., Chen D. H., Chung J. S., Kwak I. S., and Cho G. J.. Causes of Death and Risk Factors for Mortality among HIV-Infected Patients Receiving Antiretroviral Therapy in Korea. 2013; 28 (7): 990-997.
[17]	Gadpayle A.K., Kumar N., Duggal A., Rewari B.B., Ravi V. Survival trend and prognostic outcome of AIDS patients according to age, sex, stages, and mode of transmission - A retrospective study at ART centre of a tertiary care hospital. JIACM 2012; 13 (4): 291-8.
[18]	Alvarez-Uria G., Naik P. K., Pakam R. and Midde M. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action, 2013; 6: 21682.
[19]	Sieleunou I., Souleymanou M., Schonenberger A., Menten J. and Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical Medicine and International Health, 2009; 14: 36-43.
[20]	Lutaloa T., Grayb R. H., Wawerb M., Sewankamboc N., Serwaddad D., Laeyendeckere O., Kiwanukaa N., Nalugodaa F., Kigozia G., Ndyanaboa A., Bwanikaa J. B., Reynoldse S. J., Quinne T. and Opendia P. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda. 2007; 21 (6).
[21]	Rupali T. P., Mannam S., Bella A., John L., Rajkumar S., Clarence P., Pulimood S. A., Samuel P., Karthik R., Abraham O. C., and Mathai D. Risk Factors for Mortality in a South Indian Population on Generic Antiretroviral. 2012; 6.